BioSig Allowed a U.S. Patent for PURE EP™ Simulator
BioSig Technologies, Inc. (BSGM)
NASDAQ:AMEX Investor Relations:
biosigtech.com
Company Research
Source: GlobeNewswire
Santa Monica, CA, June 06, 2019 (GLOBE NEWSWIRE) -- ??BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the U.S. Patent & Trademark Office allowed a U.S. patent application covering its electrophysiology simulator. The patent application number 15/103,278 entitled, "Systems and Methods For Evaluation of Electrophysiology Systems" was filed on June 9, 2016. The patent has not yet been published. The allowed claims address a system for determining the accuracy of an EP recorder or a mapping system in the acquisition of cardiac signals. The simulator is designed to generate digital or analog simulated waveforms for electrocardiograms, unipolar or bipolar electrograms or cardiac activation maps. The PURE EP™ Simulator has been previously evaluated for a commercialization pathway by Health Research
Show less
Read more
Impact Snapshot
Event Time:
BSGM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSGM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSGM alerts
High impacting BioSig Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
BSGM
News
- BioSig Technologies, Inc. (NASDAQ: BSGM) had its price target raised by analysts at Ascendiant Capital Markets from $2.50 to $2.75. They now have a "buy" rating on the stock.MarketBeat
- BioSig Regains Compliance with Nasdaq’s Minimum Bid Price RequirementGlobeNewswire
- BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel [Yahoo! Finance]Yahoo! Finance
- BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ PanelGlobeNewswire
BSGM
Analyst Actions
- 12/5/24 - Ascendiant Capital